Clinical Trial
Published on 26 Sep 2025
Pharmacokinetics, safety and tolerability of ipatasertib in combination with palbociclib and fulvestrant in patients with advanced breast cancer in a phase Ib study
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1670582
- 2,353 views


